EASL Recommendations on Treatment of Hepatitis C 2018

Abstract

Keywords

• National Center for Biotechnology Information
• NCBI
• NLM
• MEDLINE
• humans
• pubmed abstract
• nih
• national institutes of health
• national library of medicine
• risk factors
• acute disease
• practice guideline
• risk assessment
• chronic disease
• hepatitis c* / diagnosis
• hepatitis c* / therapy
• investigators=[]
• affs=[])
• pmid:29650333
• doi:10.1016/j.jhep.2018.03.026
• collabauthor(name='european association for the study of the liver. electronic address: easloffice@easloffice.eu'
• collabauthor(name='european association for the study of the liver'
• diagnostic screening programs / organization & administration
• hepatitis c* / physiopathology
• patient care management* / methods
• patient care management* / standards

How to cite

Type this key in a SciMatic manuscript or in Thesis Manager to cite this paper automatically.

References

No references are recorded for this paper yet.